Affymax, Inc. (AFFY)
OTCMKTS · Delayed Price · Currency is USD
0.0010
0.00 (0.00%)
Oct 8, 2025, 8:00 PM EDT
Affymax Market Cap
Affymax has a market cap or net worth of $74.49 thousand as of October 10, 2025. Its market cap has decreased by -83.87% in one year.
Market Cap
74.49K
Enterprise Value
n/a
Revenue
42.00K
Ranking
n/a
PE Ratio
0.01
Stock Price
$0.00
Market Cap Chart
Since December 15, 2006, Affymax's market cap has decreased from 484.83M to 74.49K, a decrease of -99.98%. That is a compound annual growth rate of -37.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2025 | 74.49K | 25.00% |
| Dec 31, 2024 | 59.59K | 33.33% |
| Dec 29, 2023 | 44.69K | -85.00% |
| Dec 30, 2022 | 297.96K | -33.33% |
| Dec 31, 2021 | 446.94K | -94.00% |
| Dec 31, 2020 | 7.45M | 300.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Glass House Brands | 678.14M |
| Elite Pharmaceuticals | 677.87M |
| Veradigm | 500.94M |
| Northwest Biotherapeutics | 368.34M |
| Nika Pharmaceuticals | 333.67M |
| CytoDyn | 324.84M |
| American Oncology Network | 287.67M |
| Silence Therapeutics | 247.98M |